PMID- 24529042 OWN - NLM STAT- MEDLINE DCOM- 20141016 LR - 20181202 IS - 1879-1360 (Electronic) IS - 0022-3999 (Linking) VI - 76 IP - 3 DP - 2014 Mar TI - The roles of BDNF, S100B, and oxidative stress in interferon-induced depression and the effect of antidepressant treatment in patients with chronic viral hepatitis: a prospective study. PG - 227-32 LID - S0022-3999(14)00005-1 [pii] LID - 10.1016/j.jpsychores.2014.01.003 [doi] AB - OBJECTIVE: The aim of the study was to research the relationship between interferon (IFN) induced depression and sociodemographic characteristics, neurotrophic factors and oxidative stress. METHODS: Sixty four cases, 34 with Chronic Hepatitis B (CHB) and 30 with Chronic Hepatitis C (CHC), were included in the study. The patients were assessed with Structured Clinical Interview for DSM-IV (SCID-I), Hamilton Anxiety Rating Scale (HARS) and Hamilton Depression Rating Scale (HDRS) at baseline on the 2nd and 6th weeks of treatment. S100 calcium binding protein B (S100B), brain-derived neurotrophic factor (BDNF), total antioxidant status (TAS) and total oxidative stress (TOS) levels were measured at the same visits. RESULTS: In total, 20 patients were diagnosed with major depression (MD) on the sixth week. A significant relationship was found between depression developed after IFN therapy and baseline HARS scores and the type of IFN-alpha. When the pretreatment levels of HDRS, HARS, S100B, BDNF, TAS, and TOS were compared to those after treatment on the 2nd week, there was a significant increase in HDRS and HARS levels and a significant decrease in the levels of S100B and BDNF. No significant change was determined for TAS and TOS levels. CONCLUSIONS: Our study suggests that the pathogenesis of IFN induced depression may involve neurotrophic factors. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Cicek, Ismet Esra AU - Cicek IE AD - Department of Psychiatry, Research and Training Hospital, Konya, Turkey. Electronic address: iezeytinci@gmail.com. FAU - Cicek, Erdinc AU - Cicek E AD - Department of Psychiatry, University of Mevlana, Faculty of Medicine, Konya, Turkey. FAU - Kayhan, Fatih AU - Kayhan F AD - Department of Psychiatry, University of Mevlana, Faculty of Medicine, Konya, Turkey. FAU - Uguz, Faruk AU - Uguz F AD - Department of Psychiatry, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. FAU - Erayman, Ibrahim AU - Erayman I AD - Department of Clinical Bacteriology and Infectious Disease, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. FAU - Kurban, Sevil AU - Kurban S AD - Department of Biochemistry, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. FAU - Yerlikaya, F Humeyra AU - Yerlikaya FH AD - Department of Biochemistry, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. FAU - Kaya, Nazmiye AU - Kaya N AD - Department of Biochemistry, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140114 PL - England TA - J Psychosom Res JT - Journal of psychosomatic research JID - 0376333 RN - 0 (Antidepressive Agents) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (S100 Calcium Binding Protein beta Subunit) RN - 0 (S100B protein, human) RN - 9008-11-1 (Interferons) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Antidepressive Agents/adverse effects/*therapeutic use MH - Brain-Derived Neurotrophic Factor/blood/*physiology MH - Depression/blood/chemically induced/*drug therapy MH - Depressive Disorder, Major/blood/chemically induced/drug therapy MH - Female MH - Hepatitis B, Chronic/*drug therapy/psychology MH - Hepatitis C, Chronic/*drug therapy/psychology MH - Humans MH - Interferons/*adverse effects/drug effects MH - Male MH - Middle Aged MH - *Oxidative Stress MH - Prospective Studies MH - S100 Calcium Binding Protein beta Subunit/blood/*physiology MH - Young Adult OTO - NOTNLM OT - Depression OT - Interferon OT - Neurotrophic factors OT - Oxidative stress EDAT- 2014/02/18 06:00 MHDA- 2014/10/17 06:00 CRDT- 2014/02/18 06:00 PHST- 2013/08/02 00:00 [received] PHST- 2013/12/09 00:00 [revised] PHST- 2014/01/07 00:00 [accepted] PHST- 2014/02/18 06:00 [entrez] PHST- 2014/02/18 06:00 [pubmed] PHST- 2014/10/17 06:00 [medline] AID - S0022-3999(14)00005-1 [pii] AID - 10.1016/j.jpsychores.2014.01.003 [doi] PST - ppublish SO - J Psychosom Res. 2014 Mar;76(3):227-32. doi: 10.1016/j.jpsychores.2014.01.003. Epub 2014 Jan 14.